![HT 29/36 [SKI 294/HT 29/36]](/static/images/cells-no_picture.jpg)
-
平臺編號：bio-68456
-
國際編號：HB-8248?
-
細胞信息： HT 29/36 [SKI 294/HT 29/36]
-
規(guī)格：frozen
-
用途：ATCC原裝細胞
-
服務(wù)費用：
加載中…… - 訂購
-
注意事項：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
HT 29/36 [SKI 294/HT 29/36]
細胞形態(tài)：淋巴樣
免疫類型：IgG3
ATCC Number：HB-8248?
數(shù)量：大量
運輸方式：凍存運輸
是否是腫瘤細胞：0
物種來源：小鼠
生長狀態(tài)：懸浮生長
規(guī)格：0.1ml Designations: HT 29/36 [SKI 294/HT 29/36]
Depositors: ?Sloan-Kettering Institute for Cancer Research
Isotype: IgG3
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against human colon adenocarcinoma
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Restrictions:The cells are distributed for research purposes only. The Memorial Sloan-Kettering Cancer Center releases the line subject to the following: 1.) The cells or their products must not be distributed to third parties. Commercial interests are the exclusive property of Memorial Sloan-Kettering Cancer Center. 2.) Any proposed commercial use of these cells must first be negotiated with The Director, Office of Industrial Affairs, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; phone (212) 639-6181; FAX (212) 717-3439.
Comments:Animals were immunized with a human colon cancer cell line (HT-29, see ATCC HTB-38 ).
The antibody reacts with human colon adenocarcinoma cells.
It does not react with frozen sections of normal adult tissues.
This is one of a panel of hybridomas (ATCC HB-8232 and ATCC HB-8240 through ATCC HB-8252 ) that can be used to diagnose and classify human gastrointestinal tract cancers.
Propagation: ATCC complete growth medium: RPMI 1640 medium with non-essential amino acids and 2% HT, 90%; fetal bovine serum, 10%
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Preservation: culture medium, 90%; DMSO, 10%
References: 3882: Cordon-Cardo C, et al. Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies. US Patent 4,579,827 dated Apr 1 1986
免疫類型：IgG3
ATCC Number：HB-8248?
數(shù)量：大量
運輸方式：凍存運輸
是否是腫瘤細胞：0
物種來源：小鼠
生長狀態(tài)：懸浮生長
規(guī)格：0.1ml Designations: HT 29/36 [SKI 294/HT 29/36]
Depositors: ?Sloan-Kettering Institute for Cancer Research
Isotype: IgG3
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against human colon adenocarcinoma
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Restrictions:The cells are distributed for research purposes only. The Memorial Sloan-Kettering Cancer Center releases the line subject to the following: 1.) The cells or their products must not be distributed to third parties. Commercial interests are the exclusive property of Memorial Sloan-Kettering Cancer Center. 2.) Any proposed commercial use of these cells must first be negotiated with The Director, Office of Industrial Affairs, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; phone (212) 639-6181; FAX (212) 717-3439.
Comments:Animals were immunized with a human colon cancer cell line (HT-29, see ATCC HTB-38 ).
The antibody reacts with human colon adenocarcinoma cells.
It does not react with frozen sections of normal adult tissues.
This is one of a panel of hybridomas (ATCC HB-8232 and ATCC HB-8240 through ATCC HB-8252 ) that can be used to diagnose and classify human gastrointestinal tract cancers.
Propagation: ATCC complete growth medium: RPMI 1640 medium with non-essential amino acids and 2% HT, 90%; fetal bovine serum, 10%
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Preservation: culture medium, 90%; DMSO, 10%
References: 3882: Cordon-Cardo C, et al. Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies. US Patent 4,579,827 dated Apr 1 1986
